feedback

Course Director

Michael Gnant, MD, FACS
Michael Gnant, MD, FACS

Medical University of Vienna
Vienna, Austria

Faculty

Pierfranco Conte
Pierfranco Conte, MD

University of Padua
Veneto Institute of Oncology (IOV) – IRCCS
Padua, Italy

Sibylle Loibl
Sibylle Loibl, MD, PhD

German Breast Group
University of Frankfurt
Neu-Isenburg, Germany

Accredited by

Oakstone Publishing, LLC

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2016-Nov-10
Expiration Date:2017-Nov-09
Estimated Time for Completion:60 minutes
Registration Required:No
Cost:Free of Charge

Target Audience

This activity has been designed to meet the educational needs of oncologists and other clinicians involved in breast cancer.

Activity Description

In this activity, experts in breast cancer discuss evidence-based strategies to optimise the development of a long-term treatment plan for patients with HER2-positive or HER2-negative breast cancer.

Educational Objectives

Upon completion of this activity, participants should be better able to:
  • Describe the latest key clinical data that inform the creation of a treatment plan for patients with HER2-positive and HER2-negative breast cancer (BC) throughout the disease continuum
  • Evaluate how these clinical data augment current approaches to managing BC from early through advanced treatment
  • Apply evidence on optimal treatment plan strategies for patients with BC to practice

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and PeerVoice. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

CME Credit Available

To receive credit, participants must complete the online activity, score 70% or higher on the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Certificates of Completion are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity.

Date of Original Release: November 10, 2016
Expiration Date: November 09, 2017

Estimated Time to Complete Activity
60 minutes

Funding Disclosure

This activity is supported by educational grants from Celgene International Sàrl and F. Hoffmann-La Roche Ltd.

Faculty and Disclosures

Course Director and Interviewee

Michael Gnant, MD, FACS
Director, Department of Surgery
Medical University of Vienna
Vienna, Austria

Michael Gnant, MD, FACS, has a financial interest/relationship or affiliation in the form of:
Consultant for Accelsiors CRO.
Grant/Research Support from AstraZeneca; Novartis; Pfizer Inc; and Roche Holding AG.
Honoraria from Amgen Inc; AstraZeneca; Celgene; GlaxoSmithKline; Novartis; and Roche Holding AG.
Advisory Board for Novartis and Roche Holding AG.

Interviewees

Pierfranco Conte, MD
Professor of Oncology
University of Padua
Head, Division of Oncology 2
Veneto Institute of Oncology (IOV) – IRCCS
Padua, Italy

Pierfranco Conte, MD, has no financial interests/relationships or affiliations in relation to this activity.

Sibylle Loibl, MD, PhD
Chair of German Breast Group, Neu-Isenburg
Associate Professor, University of Frankfurt
Neu-Isenburg, Germany

Sibylle Loibl, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Honorarium from Pfizer Inc.

Medical Director

Serena Welch
PeerVoice

Serena Welch has no financial interests/relationships or affiliations in relation to this activity.

Faculty Disclosure Statement / Conflict of Interest Policy

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Disclosure of Unlabelled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

About This PeerCME Activity

PeerVoice and Oakstone Publishing, LLC, are responsible for the selection of this activity's topics, the preparation of educational content, and the distribution of this activity. The preparation of PeerCME activities is supported by written agreements that clearly stipulate and enforce the independence of PeerVoice, Oakstone Publishing, LLC, and the faculty presenters.

The faculty may discuss unapproved products or uses of these products in certain jurisdictions. Faculty presenters have been advised to disclose any reference to an unlabelled or unapproved use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions.

For approved prescribing information, please consult the manufacturer's product monograph.

Copyright © 2012-2016, PeerCME

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.